Bellerophon Reports 2015 Third Quarter Operational and Financial Results

Go back to Bellerophon Reports 2015 Third Quarter Operational and Financial Results

Bellerophon Therapeutics (BLPH) Tops Q3 EPS by 8c

November 12, 2015 6:18 AM EST

Bellerophon Therapeutics (NASDAQ: BLPH) reported Q3 EPS of ($0.86), $0.08 better than the analyst estimate of ($0.94).

For earnings history and earnings-related data on Bellerophon Therapeutics (BLPH) click here.

... More